Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 9
Submit an article Journal homepage
344
Views
58
CrossRef citations to date
0
Altmetric
Review

The potential of cord blood stem cells for use in regenerative medicine

David T Harris University of Arizona, Department of Immunobiology, 1501 N. Campbell Avenue, AZ 85724, Tucson, USA; University of Arizona, Cord Blood Registry, 6550 S. Bay Colony Drive, Tucson, AZ 85706, USA +1 520 626 5127; +1 520 626 2100; [email protected]
, PhD,
Michael Badowski University of Arizona, Department of Immunobiology, 1501 N. Campbell Avenue, AZ 85724, Tucson, USA
,
Nafees Ahmad University of Arizona, Department of Immunobiology, 1501 N. Campbell Avenue, AZ 85724, Tucson, USA
, PhD &
Mohamed A Gaballa University of Arizona, Sarver Heart Center, 1501 N. Campbell Avenue, AZ 85724, Tucson, USA
, PhD
Pages 1311-1322 | Published online: 29 Aug 2007

Bibliography

  • MCGUCKIN C, FORRAZ N, BARADEZ MO et al.: Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. (2005) 38:245-255.
  • KOGLER G, SENSKEN S, AIREY JA et al.: A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. (2004) 200(2):123-135.
  • WAGNER W, WEIN F, SECKINGER A: Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue and umbilical cord blood. Exp. Hematol. (2005) 22:1402-1416.
  • SARUGASSER R, LIKORISH D, BAKSH D, HOSSEINI M, DAVIES JE: Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitor cells. Stem Cells (2005) 23:220-229.
  • TONDREAU T, MEULEMAN N, DELFORGE A et al.: Mesenchymal stem cells derived from CD133-positive cells in mobilized blood and cord blood: proliferation, Oct 4 expression and plasticity. Stem Cells (2005) 23:1105-1112.
  • TRAGGAI E, CHICHA L, MAZZUCHELLI L et al.: Development of a human adaptive immune system in cord blood cell-transplanted mice. Science (2004) 304:14-107.
  • FURFARO MEK, GABALLA MA: Do adult stem cells ameliorate the damaged myocardium? Is human cord blood a potential source of stem cells? Curr. Vasc. Pharm. (2007) 5:27-44.
  • MA N, STAMM C, KAMINSKI A et al.: Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid mice. Cardiovasc. Res. (2005) 66:45-54.
  • AMADO LC, SALIARIS AP, SCHULERI KH et al.: Cardiac repair with intramyocardial injection of mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA (2005) 102:11474-11479.
  • SUNKOMAT JNE, GOLDMAN S, HARRIS DT et al.: Cord blood-derived MNCs delivered intracoronary contribute differently to vascularization compared to CD34+ cells in the rat model of acute ischemia. Stem Cells (2007) (In Press).
  • BOTTA R, GAO E, STASSI G et al.: Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells ad low dose CD34+KDR+ cells. FASEB J. (2004) 18:1392-1394.
  • HENNING RJ, ABU-ALI H, BALIS JU et al.: Human umbilical cord blood mononuclear cells for treatment of acute myocardial infarction. Cell Transplant. (2004) 13:729-739.
  • CHEN HK, HUNG HF, SHYU KG et al.: Combined cord blood cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction. Eur. J. Clin. Invest. (2005) 35:677-686.
  • HIRATA Y, SATA M, MOTOMURA N et al.: Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. (2005) 327:609-614.
  • KIM BO, TIAN H, PRASONGSUKARN K et al.: Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation (2006) 112(9 Suppl.):196-204.
  • LEOR J, GUETTA E, FEINBERG MS et al.: Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infracted myocardium. Stem Cells (2006) 24(3):772-780.
  • BONNANO G, MARIOTTI A, PROCOLI A et al.: Human cord blood CD133+ cells imunoselected by a clinical-grade apparatus differentiate in vitro into endothelial and cardiomyocyte-like cells. Transfusion (2007) 47:280-289.
  • SCHMIDT D, BREYMANN Y, WEBER A et al.: Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Soc. Thorac. Surg. (2004) 78:2094-2098.
  • MURGA M, YAO L, TOSATO G: Derivation of endothelial cells from CD34- umbilical cord blood. Stem Cells (2004) 22:385-395.
  • HOERSTRUP SP, KADNER A, BREYMANN CI et al.: Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann. Thorac. Surg. (2002) 74:46-52.
  • SCHMIDT D, MOL A, NEUENSCHWANDER S et al.: Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur. J. Cardiothorac. Surg. (2005) 27:795-800.
  • MUROHARA T, IKEDA H, DUAN A et al.: Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. (2000) 105:1527-1536.
  • GOLDBERG JL, LAUGHLIN MJ: UC blood hematopoietic stem cells and therapeutic angiogenesis. Cytotherapy (2007) 9(1):4-13.
  • NIEDA M, NICOL A, DENNING-KENDALL P et al.: Endothelial cell precursors are normal components of human umbilical cord blood. Br. J. Hematol. (1997) 98:775-777.
  • MUROHARA T: Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends Cardiovasc. Med. (2001) 11:303-307.
  • IKEDA Y, FUKADA N, WADA M et al.: Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene. Hypertens. Res. (2004) 27(2):119-128.
  • CHO S-W, GWAK S-J, KANG S-W et al.: Enhancement of angiogenic efficacy of human cord blood cell transplantation. Tissue Eng. (2006) 12(6):1651-1661.
  • FINNEY MR, GRECO NJ, HAYNESWORTH SE et al.: Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biol. Blood Marrow Transplant. (2006) 12:585-593.
  • PESCE M, ORLANDI A, IACHINIOTO MG et al.: Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissue. Circ. Res. (2003) 93:51-62.
  • SCHMIDT D, MOL A, ODERMATT B et al.: Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng. (2006) 12(11):3223-3232.
  • CANIZO MC, LOZANO F, GONZALEZ-PORRAS JR et al.: Peripheral endothelial progenitor cells (CD133+) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up. Cytotherapy (2007) 9(1):99-102.
  • VOLTARELLI JC, COURI CEB, STRACIERI ABP et al.: Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed Type 1 diabetes mellitus. JAMA (2007) 297(14):1568-1576.
  • HALLER MJ, COOPER SC, BRUSCO T et al.: Autologous cord blood transfusion associated with prolonged honeymoon in a child with Type 1 diabetes. Diabetes (2005) 53(Suppl. 1):Poster A485.
  • ENDE N, CHEN R, REDDI AS: Effect of human umbilical cord blood cells on glycemia and insulinitis in Type 1 diabetic mice. Biochem. Biophys. Res. Commun. (2004) 325:665-669.
  • ENDE N, CHEN R, MACK R: NOD/LtJ Type I diabetes in mice and the effect of stem cells (Berashis) derived from human umbilical cord blood. J. Med. (2002) 33:181-187.
  • ENDE N, CHEN R, REDDI AS: Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in Type 2 diabetic mice. Biochem. Biophys. Res. Commun. (2004) 321:168-171.
  • SUN B, ROH K-H, LEE S-R, LEE Y-S, KANG K-S: Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structures. Biochem. Biophys. Res. Commun. (2007) 354(4):919-923.
  • MCGUCKIN CP, FORRAZ N, ALLOUARD Q, PETTENGELL R: Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp. Cell Res. (2004) 295:350-359.
  • JANG YK, PARK JJ, LEE MC et al.: Retinoic acid-mediated induction of neurons and glial cells from human umbilical cord-derived hematopoietic stem cells. J. Neurosci. Res. (2004) 75:573-584.
  • BUZANSKA L, JURGA M, STACHOWIAK EK, STACHOWIAK MK, DOMANSKA-JANIK K: Neural stem-like cell line derived from a nonhematopoietic population of human umbilical cord blood. Stem Cells Develop. (2006) 15:391-406.
  • CHEN N, HUDSON JE, WALCZAK P et al.: Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells (2005) 23:1560-1570.
  • HARRIS DT, AHMAD N, SAXENA SK et al.: The Potential of Cord Blood Stem Cells for Use in Tissue Engineering. TESi Meeting. Shanghai, China (October 2005) (Abstract).
  • CHEN J, SANBERG PR, LI Y et al.: Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke (2001) 32:2682-2688.
  • WILLING AE, LIXIAN J, MILLIKEN M et al.: Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. (2003) 73(3):296-307.
  • BORLONGAN CV, HADMAN M, SANBERG CD, SANBERG PR: Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke (2004) 35:2385-2389.
  • NEWMAN MB, WILLING AE, MANRESSA JJ, SANBERG CD, SANBERG PR: Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp. Neurol. (2006) 199(1):201-208.
  • VENDRAME M, CASSADY J. NEWCOMB J et al.: Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke (2004) 35:2390-2395.
  • XIAO J, NAN Z, MOTOOKA Y, LOW WC: Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev. (2005) 14:722-733.
  • NEWCOMB JD, AJRNO CT, SANBERG CD et al.: Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. (2006) 15:213-223.
  • NAN Z, GRANDE A, SANBERG CD, SANBERG PR, LOW WC: Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann. NY Acad. Sci. (2005) 1049(1):84-96.
  • BLISS T, GUZMAN R, DAADI M, STEINBERG GK: Cell transplantation therapy for stroke. Stroke (2007) 38:817-826.
  • SAPORTA S, KIM JJ, WILLING AE et al.: Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J. Hematother. Stem Cell Res. (2003) 12:271-278.
  • KUH SU, CHO YE, YOON DH et al.: Functional recovery after human umbilical cord blood cells transplantation with brain derived-neurotropic factor into the spinal cord injured rats. Acta Neurochir. (Wein.) (2005) 14:985-992.
  • KANG KS, KIM SW, OH YH et al.: Thirty-seven-year old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy (2005) 7:368-373.
  • LU D, SANBERG PR, MAHMOOD A et al.: Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. (2002) 11:275-281.
  • MEIER C, MIDDLEANIS J, WASIELEWSKI B et al.: Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Ped. Res. (2006) 59:244-249.
  • ENDE N, CHEN R: Parkinson's disease mice and human umbilical cord blood.J. Med. (2002) 33:173-180.
  • GAEBUZOVA-DAVIS S, WILLING AE, ZIGOVA T et al.: Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J. Hematother. Stem Cell Res. (2003) 12:255-270.
  • LU X, LI S, CHENG J: Bone marrow mesenchymal stem cells: progress in bone/cartilage defect repair. J. Biomed. Eng. (Chinese) (2002) 19(1):135-139.
  • WANG FS, YANG KD, WANG CJ et al.: Shockwave stimulates oxygen radical-mediated osteogenesis of the mesenchymal cells from human umbilical cord blood. J. Bone Miner. Res. (2004) 19:973-982.
  • WAKITANI S, MITSUOKA T, NAKAMURA N et al.: Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant. (2004) 13(5):595-600.
  • SZIVEK JA, WILEY D, COX L, HARRIS D, MARGOLIS DS, GRANA WA: Stem cells grown in dynamic culture on micropatterned surfaces can be used to engineer cartilage-like tissue. Orthopaedic Research Society Meeting. San Diego, USA (2007) (Abstract).
  • THOMAS HS: Stem cell therapy tackles injured tendons and ligaments. Quarter. Horse News (2004)15:90-93.
  • GERMAIN L, AUGER FA, GRANDBOIS E et al.: Reconstructed human cornea produced in vitro by tissue engineering. Pathobiology (1999) 67:140-147.
  • GERMAIN L, CARRIER P, AUGER FA, SALESSE C, GUERIN SL: Can we produce a human corneal equivalent by tissue engineering? Prog. Retinal Eye Res. (2000) 19(5):497-527.
  • HARRIS DT, HE X, CAMACHO D, GONZALEZ V, NICHOLS JC: The Potential of Cord Blood Stem Cells for Use in Tissue Engineering of the Eye, Stem Cells & Regenerative Medicine. San Francisco, USA (23 – 25 January 2006) (Abstract).
  • HARRIS DT, HE X, BADOWSKI M, NICOLS JC: Regenerative Medicine of the Eye: A Short Review. Stem Cell Repair & Regeneration. Volume 3. Levicar N, Habib NA, Dimarakis I, Gordon MY (Eds), Imperial College Press, London, UK (2007) (In Press).
  • NICHOLS JC, HE X, HARRIS DT: Differentiation of cord blood stem cells into corneal epithelium. Invest. Ophthalmol. Vis. Sci. (2005) 46:E4772.
  • MA Y, XU Y, XIAO A et al.: Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells (2006) 24(2):315-321.
  • KAKINUMA S, TANAKA Y, CHINZEI R et al.: Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells (2003) 21:217-227.
  • TANG XP, ZHANG M, YANG X et al.: Differentiation of human umbilical cord blood stem cells into hepatocytes in vivo and in vitro. World J. Gastroenterol. (2006) 12:4014-4019.
  • PETERS RE, MOCK M, MEIER P et al.: Differentiation of non-adherent hematopoietic stem cells from umbilical cord blood cells into adherent hepatocytic lineage. ASH Conference. Orlando, FL, USA (2006):Poster #756-II.
  • BERGER MJ, ADAMS SD, TIGGES BM et al.: Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells. Cytotherapy (2006) 8:480-487.
  • BADIAVAS EV, ABEDI M, BUTMARC J, FALANGA V, QUESENBERRY P: Participation of bone marrow derived cells in cutaneous wound healing. J. Cell Physiol. (2003) 196:245-250.
  • VALBONESI M, GIANNINI G, MIGLIORI F, DALLA COSTA R, DEJANA AM: Cord blood (CB) stem cells for wound repair. Preliminary report of 2 cases. Transfus. Apher. Sci. (2004) 30(2):153-156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.